Centenial Surgical Suture Complete Financial Statements
In FYNone, Centenial Surgical Suture (CSURGSU) reported revenue ₹55 Cr, net profit ₹-1 Cr and EPS ₹-3.00, with a net profit margin of -3.7% and ROE of -6.5%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore CSURGSU value investing to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CSURGSU Revenue, Net Profit & EBITDA — Year-on-Year Growth
CSURGSU YoY (March 2025 vs Period) — revenue +1.9%, net profit +50.0%, expenses +2.1%. For live price, earnings ratios and company overview, see CSURGSU share price screener.
CSURGSU Income Statement — Revenue, EBITDA & Net Profit
Centenial Surgical Suture revenue ₹55 Cr, EBITDA ₹6 Cr, net profit ₹-1 Cr, EPS ₹-3.00 (None) — net profit margin -3.7%. Review CSURGSU earnings multiple to evaluate earnings-based valuation against sector peers.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55 | 54 | 51 | 53 | 45 | 37 | 56 | 56 | 53 | 53 | 52 | 52 |
| Expenses | 48 | 47 | 46 | 48 | 40 | 32 | 50 | 51 | 48 | 48 | 47 | 47 |
| EBITDA | 6 | 6 | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 |
| Operating Profit Margin % | 11.00% | 12.00% | 10.00% | 8.00% | 10.00% | 14.00% | 10.00% | 9.00% | 8.00% | 9.00% | 9.00% | 10.00% |
| Depreciation | 4 | 4 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Interest | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Profit Before Tax | -1 | -2 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 | 2 | 3 |
| Tax | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | -1 | -2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Earnings Per Share (₹) | -3.00 | -4.01 | 3.11 | 2.43 | 1.72 | 2.64 | 3.55 | 5.53 | 4.23 | 4.71 | 4.28 | 5.25 |
CSURGSU Balance Sheet — Assets, Liabilities & Shareholders' Equity
CSURGSU total assets ₹85 Cr, total equity ₹31 Cr, total liabilities ₹ Cr (2025) — ROE -6.5%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 85 | 79 | 66 | 61 | 70 | 69 | 57 | 55 | 56 | 53 | 55 |
| Current Assets | 63 | 65 | 59 | 53 | 61 | 58 | 52 | 51 | 52 | 49 | 51 |
| Fixed Assets | 20 | 13 | 7 | 8 | 9 | 10 | 4 | 4 | 4 | 4 | 4 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 65 | 66 | 60 | 54 | 61 | 59 | 53 | 51 | 52 | 49 | 51 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 22 | 14 | 6 | 7 | 9 | 10 | 3 | 3 | 3 | 3 | 3 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 31 | 32 | 31 | 30 | 30 | 29 | 28 | 26 | 25 | 23 | 21 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 25 | 27 | 26 | 25 | 24 | 23 | 23 | 21 | 19 | 17 | 16 |
CSURGSU Cash Flow Statement — Operating, Investing & Financing
Centenial Surgical Suture operating cash flow ₹17 Cr, investing ₹-12 Cr, financing ₹-6 Cr, net cash flow ₹-1 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 17 | 6 | 1 | 5 | 2 | 2 | 2 | 2 | 0 | -2 | 0 |
| Investing Activities | -12 | -8 | 0 | 0 | -1 | -1 | -1 | -1 | -2 | 0 | 0 |
| Financing Activities | -6 | 2 | -1 | -5 | -1 | 0 | -1 | -1 | 2 | 1 | 1 |
| Net Cash Flow | -1 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | -1 | 1 |